TECH

BIO-TECHNE Corp

Biological Products, (No Diagnostic Substances) · SIC 2836CIK 842023Held by 13 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

13 managers · Q2 2026 13F

13F bookWeight

Ruane Cunniff

Ruane CunniffPosition history →

3.7%

(1.3%)

$236.6M

$6.43B13F book · 2026-06-30

Weitz Investment Management

Wallace WeitzPosition history →

2.7%

(16.8%)

$38.4M

$1.44B13F book · 2026-06-30

Mairs & Power

Mairs & PowerPosition history →

1.8%

(1.8%)

$190.8M

$10.90B13F book · 2026-06-30

Maverick Capital

Lee AinsliePosition history →

0.98%

(67.6%)

$108.5M

$11.08B13F book · 2026-06-30

Soros Fund Management

Soros family officePosition history →

0.50%

NEW

$37.8M

$7.62B13F book · 2026-06-30

Royce & Associates

Royce & AssociatesPosition history →

0.45%

+4.0%

$55.8M

$12.42B13F book · 2026-06-30

Durable Capital Partners

Henry EllenbogenPosition history →

0.34%

(88.7%)

$35.5M

$10.28B13F book · 2026-06-30

Glenview Capital Management

Glenview Capital ManagementPosition history →

0.08%

(68.7%)

$4.1M

$5.01B13F book · 2026-06-30

Adage Capital Management

Adage Capital ManagementPosition history →

0.04%

+476.2%

$27.5M

$71.32B13F book · 2026-06-30

Capital Research Global Investors

Capital Research Global InvestorsPosition history →

0.03%

(17.8%)

$185.2M

$716.87B13F book · 2026-06-30

WCM Investment Management

WCM Investment ManagementPosition history →

0.03%

(0.3%)

$14.0M

$55.16B13F book · 2026-06-30

Bridgewater Associates

Bridgewater AssociatesPosition history →

0.01%

+347.5%

$1.9M

$24.38B13F book · 2026-06-30

Capital World Investors

Capital World InvestorsPosition history →

<0.01%

+73.3%

$37.9M

$846.43B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.